Slides
Page 1
Investor Presentation November 8, 2025 Anthem Biosciences Limited
Page 2
Safe Harbour Except for the historical information contained herein, statements in this presentation and the subsequent discussions, which include words or phrases such as "will", "aim", "will likely result", "would", "believe", "may", "expect", "will continue", "anticipate", "estimate", "intend", "plan", "contemplate", seek to", "future", "objective", "goal", "likely", "project", "should", "potential", "will pursue", and similar expressions of such expressions may constitute “forward-looking statements”. These forward-looking statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those suggested by the forward-looking statements. These risks and uncertainties include but are not limited to our ability to successfully implement our strategy, our growth and expansion plans, obtain regulatory approvals, our provisioning policies, technological changes, investment and business income, cash flow projections, our exposure to market risks as well as other risks. The Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date thereof.
Page 3
Consolidated Profit & Loss Statement: Q2FY26 vs Q2FY25 vs Q1FY26 Performance 3 Particulars (₹ Mn) Q2FY26 Q2FY25 YoY Q1FY26 QoQ FY25 Revenue from Operations 5,500 5,250 4.8% 5,402 1.8% 18,446 CRDMO 4,719 4,351 8.5% 4,527 4.2% 15,061 Specialty Ingredients 781 899 -13.1% 875 -10.7% 3,385 Other Income 482 278 73.2% 228 111.4% 857 Total Revenues 5,983 5,528 8.2% 5,630 6.3% 19,303 Cost of materials consumed and changes in inventories 2,234 1,879 18.9% 2,309 -3.3% 7,439 Employee benefits expense 677 964 -29.7% 720 -6.0% 2,605 Other expenses 410 455 -9.8% 458 -10.4% 1,693 EBITDA 2,661 2,231 19.3% 2,143 24.2% 7,566 EBITDA Margins 44.5% 40.4% 10.2% 38.1% 16.9% 39.2% Finance cost 30 36 -14.6% 16 88.3% 103 Depreciation and amortization expense 335 200 67.6% 264 26.7% 894 Profit before tax 2,296 1,995 15.1% 1,862 23.3% 6,569 Total tax expense 562 376 49.4% 505 11.3% 2,056 Profit after tax 1,734 1,619 7.1% 1,358 27.7% 4,513